Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.

Publication Type:

Journal Article


Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Volume 17, Issue 10, p.2609-18 (2008)


2008, Aged, Colorectal Neoplasms, Double-Blind Method, Estrogens, Conjugated (USP), Female, Humans, Incidence, Middle Aged, Placebos, Postmenopause, Proportional Hazards Models, Public Health Sciences Division, Risk Factors, Survival Analysis, United States


In separate Women's Health Initiative randomized trials, combined hormone therapy with estrogen plus progestin reduced colorectal cancer incidence but estrogen alone in women with hysterectomy did not. We now analyze features of the colorectal cancers that developed and examine the survival of women following colorectal cancer diagnosis in the latter trial.